Treating Type 1 Diabetes Mellitus with a Rapid-Acting Analog Insulin Regimen vs. Regular Human Insulin in Germany: A Long-Term Cost-Effectiveness Evaluation-Reference-Cited by-同舟云学术

Treating Type 1 Diabetes Mellitus with a Rapid-Acting Analog Insulin Regimen vs. Regular Human Insulin in Germany: A Long-Term Cost-Effectiveness Evaluation

Published:2018-03-10 Issue:3 Volume:16 Page:357-366
ISSN:1175-5652
Container-title:Applied Health Economics and Health Policy
language:en
Short-container-title:Appl Health Econ Health Policy

Author:

Valentine William J.,Van Brunt Kate,Boye Kristina S.,Pollock Richard F.^ORCID

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics and Econometrics,General Medicine

Link

http://link.springer.com/article/10.1007/s40258-018-0379-5/fulltext.html

Reference44 articles.

1. IDF Atlas, Version 6. 2015. https://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf . Accessed 22 Dec 2015.

2. Bächle C, Icks A, Straßburger K, Flechtner-Mors M, Hungele A, Beyer P, Placzek K, Hermann U, Schumacher A, Freff M, Stahl-Pehe A, Holl RW. Rosenbauer J; DPV Initiative and the German BMBF Competence Network Diabetes Mellitus. Direct diabetes-related costs in young patients with early-onset, long-lasting type 1 diabetes. PLoS One. 2013;8(8):e70567.

3. Köster I, Hauner H, von Ferber L. Heterogeneity of costs of diabetic patients: the Cost of Diabetes Mellitus Study. Dtsch Med Wochenschr. 2006;131(15):804–10.

4. von Ferber L, Köster I, Hauner H. Medical costs of diabetic complications total costs and excess costs by age and type of treatment results of the German CoDiM Study. Exp Clin Endocrinol Diabetes. 2007;115(2):97–104.

5. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet. 2009;373(9680):2027–33.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse drug events in cost-effectiveness models of pharmacological interventions for diabetes, diabetic retinopathy, and diabetic macular edema: a scoping review;JBI Evidence Synthesis;2024-07-29

2. Review and estimation of disutility for joint health states of severe and nonsevere hypoglycemic events in diabetes;Journal of Comparative Effectiveness Research;2021-09

3. Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy;The European Journal of Health Economics;2020-10-06

4. The cost-effectiveness of insulin analogs and regular insulin for diabetes control: a case study in Iran;International Journal of Health Care Quality Assurance;2020-05-11

5. Legitimacy and potential savings in automatic substitution of biological products in Poland, the example of insulin;Acta Poloniae Pharmaceutica - Drug Research;2018-10-31